Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	NIHR Horizon Scanning Centre (NIHR HSC)	NeuroAD™ for mild and moderate Alzheimer's Disease
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Saxagliptin (Onglyza®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Patient lifts and transfer equipment for preventing pressure ulcers: a review of clinical and cost-effectiveness and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	Water birth
2013	New Zealand National Health Committee (NHC)	Renal denervation – technology note
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Bucelipase-alfa (Kiobrina) for pre-term infants
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Lixisenatide (Lyxumia®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Esophageal doppler ultrasound-based cardiac output monitoring for adults undergoing surgery: a review of clinical and cost-effectiveness
2013	New Zealand National Health Committee (NHC)	Percutaneous interventions for mitral regurgitation - technology Note
2013	NIHR Horizon Scanning Centre (NIHR HSC)	ICES13 for stress urinary incontinence in women - second line
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Sodium phenylbutyrate (Pheburane®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Blood glucose monitors and test strips: a review of the comparative clinical evidence and cost-effectiveness — an update
2013	New Zealand National Health Committee (NHC)	Left atrial appendage – technology note
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for Shiga-Toxin producing Escherichia coli Haemolytic-Uraemic Syndrome – first line
2013	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Etravirine (Intelence®)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drug therapies for immunosuppression in adult patients following islet cell transplantation for the treatment of diabetes: clinical and cost-effectiveness
2013	New Zealand National Health Committee (NHC)	New and emerging cardiac technologies in Australian and New Zealand public health service over the next decade
2013	NIHR Horizon Scanning Centre (NIHR HSC)	NephroCheck® Test for assessing risk of acute kidney injury
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	JC virus antibody testing for patients with MS: a review of the diagnostic accuracy and guidelines
2013	Malaysian Health Technology Assessment (MaHTAS)	Transcranial Doppler (TCD) ultrasound and cerebral computed tomography perfusion (CTP) for aneurysmal subarachnoid haemorrhage (SAH)
2013	New Zealand National Health Committee (NHC)	Ventilation tubes: an opportunity for better targeting - technology note
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Nintedanib for idiopathic pulmonary fibrosis – first line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Treatment of patients with multiple sclerosis: a review of guidelines
2013	NIHR Public Health Research (PHR) programme	Systematic review of the effects of schools and school environment interventions on health: evidence mapping and synthesis
2013	NIHR Health Technology Assessment programme	Management of Asthma in School age Children On Therapy (MASCOT): a randomised, double-blind, placebo-controlled, parallel study of efficacy and safety
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ustekinumab (Stelara) for plaque psoriasis in adolescents
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tinzaparin versus dalteparin or enoxaparin for the treatment of venous thromboembolism in adults: safety and guidelines
2013	NIHR Public Health Research (PHR) programme	Systematic review of the effects of schools and school environment interventions on health: evidence mapping and synthesis
2013	NIHR Health Technology Assessment programme	A cluster randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of classroom-based cognitive-behavioural therapy (CBT) in reducing symptoms of depression in high-risk adolescents
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques to improve the use of diagnostic laboratory test ordering: clinical evidence
2013	NIHR Public Health Research (PHR) programme	Reducing alcohol-related harm in disadvantaged men: development and feasibility assessment of a brief intervention delivered by mobile telephone
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Pazopanib (Votrient) for renal cell carcinoma – adjuvant therapy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibiotic prophylaxis for patients with cardiac or orthopedic implants undergoing dental procedures: a review of the clinical effectiveness and guidelines
2013	NIHR Public Health Research (PHR) programme	Community engagement to reduce inequalities in health: a systematic review, meta-analysis and economic analysis
2013	NIHR Health Technology Assessment programme	A cluster randomised controlled trial of a manualised cognitive behavioural anger management intervention delivered by supervised lay therapists to people with intellectual disabilities
2013	NIHR Health Technology Assessment programme	A systematic review and cost-effectiveness analysis of specialist services and adrenaline auto-injectors in anaphylaxis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ponatinib (Iclusig) for chronic myeloid leukaemia
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Biologic response modifier agents as first-line treatment for patients with rheumatoid arthritis: a review of the clinical efficacy, cost-effectiveness and guidelines
2013	NIHR Health Technology Assessment programme	Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ramucirumab monotherapy for advanced gastric cancer and gastro-oesophageal junction adenocarcinoma – after prior chemotherapy
2013	NIHR Health Technology Assessment programme	Pixantrone monotherapy for the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bone morphogenetic proteins for use in spinal surgery and long bone trauma surgery: a review of the clinical effectiveness and safety
2013	NIHR Health Technology Assessment programme	Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Carfilzomib for relapsed and/or refractory multiple myeloma
2013	NIHR Health Technology Assessment programme	Pemetrexed for maintenance treatment following induction therapy with pemetrexed and cisplatin for non-squamous non-small cell lung cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal management systems for hospitalized adult patients: comparative clinical effectiveness and safety
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Lenalidomide (Revlimid) for mantle cell lymphoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Osteostimulative bone graft substitutes or demineralized bone matrix preparations for use in spinal Surgery and long bone trauma surgery: clinical effectiveness and safety
2013	NIHR Health Technology Assessment programme	Risk Adjustment In Neurocritical care (RAIN) - prospective validation of risk prediction models for adult patients with acute traumatic brain injury to use to evaluate the optimum location and comparative costs of neurocritical care: a cohort study
2013	NIHR Health Technology Assessment programme	Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Liposomal cisplatin (Lipoplatin) in combination with fluorouracil for head and neck cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fusidic acid for ophthalmic infections: a review of clinical and cost effectiveness and safety
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab for non-small cell lung cancer – second line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The timing of prophylactic antibiotics for surgery: a review of the clinical Evidence
2013	NIHR Health Technology Assessment programme	Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Paclitaxel polyglutamate (Opaxio) in combination with temozolamide and radiotherapy for glioblastoma – first line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography guided versus ultrasound guided renal biopsy: comparative evidence
2013	NIHR Horizon Scanning Centre (NIHR HSC)	PROSTVAC Immunotherapy for chemotherapy-naïve hormone-relapsed prostate cancer
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prioritizing patients undergoing non-urgent, medically necessary cosmetic surgical procedures: clinical evidence and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Lymphoseek® for lymphatic mapping and sentinel lymph node location in breast cancer, head and neck cancer and melanoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Codeine compared with other opioids for pain relief in pediatric patients: comparative clinical effectiveness, safety, and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	CardioMEMs HF System for heart failure
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Meperidine to relieve shivering or bladder spasm: clinical effectiveness
2013	NIHR Horizon Scanning Centre (NIHR HSC)	C-Pulse® Heart assist system for heart failure
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Inhaled tobramycin versus intravenous tobramycin for patients with cystic fibrosis: a review of the clinical effectiveness, cost effectiveness, and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	BioMimics 3D™ stent for peripheral artery disease
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibiotics for the prevention of post-cesarean section complications: clinical evidence and safety
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Revivent™ for heart failure with left ventricular scar
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal timing and frequency of follow-up care for patients receiving at-home supplemental oxygen: clinical evidence and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Liraglutide for obesity or overweight in patients with associated co-morbidities
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Wrist sphygmomanometry versus upper arm sphygmomanometry: clinical effectiveness and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Macula Risk PGx test for dry age-related macular degeneration
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	The use of dental crowns for vital and endodontically treated teeth: a review of the clinical and cost-effectiveness and guidelines
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Kappaproct for ulcerative colitis – third line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Chlorhexidine for the prevention of surgical site infections: clinical effectiveness and guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Stroke prevention in atrial fibrillation
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Enzalutamide, MDV3100 (Xtandi®) for patients with progressive castration-resistant prostate cancer previously treated with docetaxel-based chemotherapy
2013	NIHR Horizon Scanning Centre (NIHR HSC)	OrganOx® metra™ for liver preservation during transplantation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Risk factors to consider for extended anticoagulant therapy: a review of guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Comparative effectiveness of psychological treatments and pharmacological treatments for adults with posttraumatic stress disorder (PTSD)
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Trastuzumab emtansine (KadcylaTM) for previously treated patients with HER2-positive advanced/metastatic breast cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	PartoSure™ Time to Delivery test in suspected premature labour
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcatheter aortic valve replacement
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Aflibercept, AVE0005 (Zaltrap®) for the treatment of patients with relapsed or refractory metastatic colorectal cancer (mCRC)
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Efraloctocog alfa (Eloctate) for haemophilia A in adults and children
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ondansetron for the management of chemotherapy-induced nausea and vomiting in pediatric patients: a review of the clinical effectiveness, safety and guidelines
2013	HAYES, Inc.	Autologous stem cell transplantation for crohn's disease
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Daclatasvir and asunaprevir for hepatitis C infection
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intranasal triamcinolone versus intranasal beclomethasone for acute and chronic sinus inflammation: a review of comparative clinical effectiveness and safety
2013	HAYES, Inc.	Bioidentical hormone replacement therapy for menopausal symptoms
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Etanercept (Enbrel) for axial spondyloarthritis without radiographic evidence of ankylosing spondylitis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Thrombolytic drugs for cardiac arrest: a review of the clinical effectiveness
2013	Belgian Health Care Knowledge Centre (KCE)	A comparative analysis of hospital care payments in five countries
2013	HAYES, Inc.	Capsule endoscopy of the small bowel for obscure gastrointestinal bleeding
2013	NIHR Horizon Scanning Centre (NIHR HSC)	ApiFix system for adolescent idiopathic scoliosis
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Discontinuation of contact precautions for antibiotic resistant organisms: clinical evidence and guidelines
2013	Belgian Health Care Knowledge Centre (KCE)	Non-small cell and small cell lung cancer: diagnosis, treatment and follow-up
2013	HAYES, Inc.	Labiaplasty for labia minora hypertrophy
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Leuco-methylthioninium (LMTX) for behavioural variant frontotemporal dementia – first line
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nitrofurantoin administration in patients with renal dysfunction: clinical effectiveness, safety, and guidelines